Work

Abstract 2914: The WEE1 inhibitor Debio 0123 is synergistic with the PKMYT1 inhibitor lunresertib in preclinical models of ovarian and breast cancer

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-2914

Authors: Luke Piggott, Diana Bianca Rocha Gomes, Paula Martinez Sanz, Violeta Serra

Institutions: Debiopharm (Switzerland), Vall d'Hebron Institute of Oncology

Language: English

Topic: Cancer-related Molecular Pathways

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409628530

Cites:

Cited by: 1

Related to: 10